HCV RNA at 12 weeks after treatment can predict sustained virologic response in chronic hepatitis C patients treated with pegylated interferon and ribavirin

被引：0
|
作者：
Yang, Sun
Lee, Joon Hyoek
Gwak, Geum-Youn
Choi, Moon Seok
Koh, Kwang Cheol
Paik, Seung Woon
Yoo, Byung Chul
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A830 / A830
页数：1
相关论文
共 50 条
  • [31] A miRNAs based multivariate signature to predict sustained virological response to pegylated-interferon plus ribavirin treatment in patients with chronic hepatitis C
    Estrabaud, Emilie
    Bieche, Ivan
    Carrat, Fabrice
    Lapalus, Martine
    De Muynck, Simon
    Lada, Olivier
    Martinot-Peignoux, Michelle
    Valla, Dominique
    Bedossa, Pierre
    Marcellin, Patrick
    Vidaud, Michel
    Asselah, Tank
    HEPATOLOGY, 2012, 56 : 687A - 688A
  • [32] Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin
    Bonardi, Renato
    Tabone, Marco
    Manca, Aldo
    Pellicano, Rinaldo
    Ciancio, Alessia
    Rizzetto, Mario
    BIOMEDICINE & PHARMACOTHERAPY, 2011, 65 (04) : 303 - 306
  • [33] GENETIC VARIATION IN ITPA POLYMORPHISM PREDICTS SUSTAINED VIROLOGIC RESPONSE (SVR) AFTER PROLONGED PEGYLATED INTERFERON AND RIBAVIRIN THERAPY IN CHRONIC HEPATITIS C (CHC) PATIENTS
    Ito, Kiyoaki
    Masaki, Naohiko
    Sugiyama, Masaya
    Mukaide, Motokazu
    Saito, Hiroaki
    Aoki, Yoshihiko
    Hiramine, Satoshi
    Matsui, Teppei
    Imamura, Masatoshi
    Murata, Kazumoto
    Mizokami, Masashi
    HEPATOLOGY, 2011, 54 : 863A - 863A
  • [34] Cytokine response in chronic hepatitis C (CHC) patients treated with pegylated interferon plus ribavirin
    Trapero-Marugan, M.
    Garcia-Buey, L.
    Munoz, C.
    Moreno-Monteagudo, J. A.
    Borque, M. J.
    Salcedo-Mora, X.
    Moreno-Otero, R.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S227 - S228
  • [35] Immunological biomarkers of virological response in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
    Menezes, E.
    Reis, J.
    Cardoso, L.
    Teixeira Carvalho, A.
    Filho, A. M. O.
    Teixeira, R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 1269 - 1269
  • [36] Cytokine response in chronic hepatitis C (CHC) patients treated with pegylated interferon plus ribavirin
    Marugán, MT
    Moreno-Otero, R
    Garcia-Buey, L
    Moreno-Monteagudo, JA
    Vitón, M
    Muñoz, C
    Borque, MJ
    Salcedo-Mora, X
    HEPATOLOGY, 2005, 42 (04) : 668A - 668A
  • [37] Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon α for chronic hepatitis C*,**
    Zeuzem, S
    Heathcote, EJ
    Shiffman, ML
    Wright, TL
    Bain, VG
    Sherman, M
    Feinman, SV
    Fried, MW
    Rasenack, J
    Sarrazin, C
    Jensen, DM
    Lin, A
    Hoffman, JH
    Sedarati, F
    JOURNAL OF HEPATOLOGY, 2003, 39 (01) : 106 - 111
  • [38] Durability of sustained virologic response in patients with chronic hepatitis C after treatment with interferon α-2b alone or in combination with ribavirin.
    McHutchison, JG
    Davis, GL
    Esteban-Mur, R
    Poynard, T
    Ling, MH
    Garaud, JJ
    Albrecht, J
    HEPATOLOGY, 2001, 34 (04) : 244A - 244A
  • [39] PREDICTING SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN USING THE ABBOTT REALTIME HCV ASSAY AND THE ROCHE COBAS TAQMAN HCV ASSAY
    Motsuuro, Kentaro
    Tanaka, Yasuhito
    Hasegawa, Izumi
    Ohno, Tomoyoshi
    Tokuda, Hiroshi
    Sugouchi, Fuminaka
    Nojiri, Shunsuke
    Mizokami, Masashi
    HEPATOLOGY, 2008, 48 (04) : 875A - 875A
  • [40] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
12345